Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT05067166
What this trial is testing

Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP

Who this might be right for
Ebola Virus Disease
Ridgeback Biotherapeutics, LP
Testing effectiveness (Phase 2)Study completedNCT05639166
What this trial is testing

Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19

Who this might be right for
COVID-19
Immune Biosolutions Inc 200
Not applicableStudy completedNCT05216588
What this trial is testing

Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

Who this might be right for
COVID-19Immunocompromised Host
ANRS, Emerging Infectious Diseases 149
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Testing effectiveness (Phase 2)Study completedNCT00694460
What this trial is testing

Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers

Who this might be right for
RabiesJapanese EncephalitisPre-Exposure Prophylaxis
Novartis 200
Large-scale testing (Phase 3)Study completedNCT05417997
What this trial is testing

Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

Who this might be right for
COVID-19 Respiratory InfectionFLUCold; Influenza+2 more
RAAS Nutritionals, LLC 71
Not applicableStudy completedNCT04898140
What this trial is testing

The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents

Who this might be right for
Covid19Respiratory Viral Infection
Moscow Department of Health 5,340
Large-scale testing (Phase 3)UnknownNCT04891172
What this trial is testing

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Who this might be right for
Covid19
Dow University of Health Sciences 310
Not applicableUnknownNCT06463912
What this trial is testing

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

Who this might be right for
Hepatitis C Virus Infection
Asociación Colombiana de Hepatología 205
Large-scale testing (Phase 3)Study completedNCT00654901
What this trial is testing

Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 881
Not applicableUnknownNCT05087277
What this trial is testing

Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain

Who this might be right for
COVID-19
Centers for Disease Control and Prevention, China 150
Testing effectiveness (Phase 2)Study completedNCT05303376
What this trial is testing

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Who this might be right for
COVID-19
Immune Biosolutions Inc 123
Not applicableStudy completedNCT05057936
What this trial is testing

Antibody After COVID-19 Vaccination

Who this might be right for
Covid19Breakthrough InfectionCKD+2 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 140
Not applicableNot Yet RecruitingNCT07809165
What this trial is testing

Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Beijing 302 Hospital 60
Not applicableStudy completedNCT00000911
What this trial is testing

Monitor Patients With Primary or Early HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Early research (Phase 1)Active Not RecruitingNCT06652958
What this trial is testing

Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

Who this might be right for
HIV Infections
ViiV Healthcare 102
Early research (Phase 1)Study completedNCT04690387
What this trial is testing

Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

Who this might be right for
COVID-19
Aivita Biomedical, Inc. 27
Not applicableActive Not RecruitingNCT07665060
What this trial is testing

HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy

Who this might be right for
HIV
NYU Langone Health 6,100
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Testing effectiveness (Phase 2)UnknownNCT05729360
What this trial is testing

Study of Monoclonal Antibodies for Early Etiotropic Therapy for Coronavirus Infection Caused by the SARS-CoV-2 Virus

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 30
Next Page